Selective induction of S100a8/a9 heterodimer protein in pancreatic cancer in response to immune selection pressure

被引：0
|
作者：
Weiner, Louis [1 ]
Ajina, Reham [1 ]
机构：
[1] Georgetown Univ, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O75
引用
收藏
页数：2
相关论文
共 50 条
  • [1] S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
    Liao, Wei-Chih
    Chen, Chih-Ta
    Tsai, You-Shu
    Wang, Xin-Ya
    Chang, Yen-Tzu
    Wu, Ming-Shiang
    Chow, Lu-Ping
    BMC CANCER, 2023, 23 (01)
  • [2] S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
    Wei-Chih Liao
    Chih-Ta Chen
    You-Shu Tsai
    Xin-Ya Wang
    Yen-Tzu Chang
    Ming-Shiang Wu
    Lu-Ping Chow
    BMC Cancer, 23
  • [3] The secreted leukocyte protein heterodimer S100A8/A9 dissociates pancreatic cell-cell contacts In Vivo
    Schnekenburger, J.
    Hlouschek, V.
    Neumann, B.
    Domschke, W.
    Kerckhoff, C.
    PANCREAS, 2007, 35 (04) : 426 - 426
  • [4] Modulation of the inflammatory response by S100A8/A9
    Sperandio, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 : 42 - 42
  • [5] S100A8/A9 in Inflammation
    Wang, Siwen
    Song, Rui
    Wang, Ziyi
    Jing, Zhaocheng
    Wang, Shaoxiong
    Ma, Jian
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [6] Development of pancreatic cancer therapy targeting S100A8/A9 of tumor microenvironment
    Kinoshita, Rie
    Tomonobu, Nahoko
    Yamauchi, Akira
    Futami, Junichiro
    Toyooka, Shinichi
    Sakaguchi, Masakiyo
    CANCER SCIENCE, 2024, 115 : 519 - 519
  • [7] The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
    Araki, Kota
    Kinoshita, Rie
    Tomonobu, Nahoko
    Gohara, Yuma
    Tomida, Shuta
    Takahashi, Yuta
    Senoo, Satoru
    Taniguchi, Akihiko
    Itano, Junko
    Yamamoto, Ken-ichi
    Murata, Hitoshi
    Suzawa, Ken
    Shien, Kazuhiko
    Yamamoto, Hiromasa
    Okazaki, Mikio
    Sugimoto, Seiichiro
    Ichimura, Kouichi
    Nishibori, Masahiro
    Miyahara, Nobuaki
    Toyooka, Shinichi
    Sakaguchi, Masakiyo
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (01): : 131 - 145
  • [8] The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
    Kota Araki
    Rie Kinoshita
    Nahoko Tomonobu
    Yuma Gohara
    Shuta Tomida
    Yuta Takahashi
    Satoru Senoo
    Akihiko Taniguchi
    Junko Itano
    Ken-ichi Yamamoto
    Hitoshi Murata
    Ken Suzawa
    Kazuhiko Shien
    Hiromasa Yamamoto
    Mikio Okazaki
    Seiichiro Sugimoto
    Kouichi Ichimura
    Masahiro Nishibori
    Nobuaki Miyahara
    Shinichi Toyooka
    Masakiyo Sakaguchi
    Journal of Molecular Medicine, 2021, 99 : 131 - 145
  • [9] Role of S100A8/A9 in Sustained
    Singer, Benjamin H.
    Denstaedt, Scott J.
    Newstead, Michael W.
    Zeng, Xianying
    Standiford, Theodore J.
    ANNALS OF NEUROLOGY, 2017, 82 : S214 - S214
  • [10] Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients
    D'Amico, F.
    Granata, M.
    Skarmoutsou, E.
    Trovato, C.
    Lovero, G.
    Gangemi, P.
    Longo, V.
    Pettinato, M.
    Mazzarino, M. C.
    INFLAMMATION RESEARCH, 2018, 67 (07) : 609 - 616
12345